Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patientsResearch in context

Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patientsResearch in context

Background: Approximately 60% of patients with colorectal cancer (CRC) undergo either local recurrence or distant metastases after surgery. Current prognostic biomarkers are insufficient to predict recurrence of CRC and provide little forecast information about what patients are likely to receive be...

Full description

Bibliographic Details
Main Authors: Dengbo Ji, Meng Qiao, Yunfeng Yao, Ming Li, Hailong Chen, Qi Dong, Jinying Jia, Xinxin Cui, Zhaowei Li, Jinhong Xia, Jin Gu
Format: Article
Language:English
Published: Elsevier 2018-09-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396418303268

Similar Items

Similar Items